Kestra Medical Technologies, Ltd. (KMTS) — Analyst outlook / Analyst consensus target is. Based on 4 analyst ratings, the consensus is bullish — 3 Buy, 1 Hold.
The consensus price target is $28.00 (low: $24.00, high: $30.00), representing an upside of 41.8% from the current price $19.74.
Analysts estimate Earnings Per Share (EPS) of $-2.29 and revenue of $0.06B for the next fiscal year.
Earnings Per Share (EPS) track record: 2025: actual $-5.13 vs est $-2.29 (missed -124.3%). Analyst accuracy: 45%.
KMTS Stock — 12-Month Price Forecast
$28.00
▲ +41.84% Upside
Average Price Target
Based on 4 Wall Street analysts offering 12-month price targets for Kestra Medical Technologies, Ltd., the average price target is $28.00, with a high forecast of $30.00, and a low forecast of $24.00.
The average price target represents a +41.84% change from the last price of $19.74.
Highest Price Target
$30.00
Average Price Target
$28.00
Lowest Price Target
$24.00
KMTS Analyst Ratings
Buy
Based on 4 analysts giving stock ratings to Kestra Medical Technologies, Ltd. in the past 3 months
EPS Estimates — KMTS
45%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2025
Actual –$5.13
vs Est –$2.29
▼ 55.4% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — KMTS
97%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2025
Actual $0.060B
vs Est $0.058B
▲ 2.6% off
Revenue Trend
Analysts expect stable revenue going forward.
